Ex­clu­sive: Tran­scend notch­es Phase 2 win to treat PTSD, in­vig­o­rat­ing bud­ding neu­ro­plas­to­gen class

Tran­scend Ther­a­peu­tics’ PTSD treat­ment suc­ceed­ed in a mid-stage study, pro­pelling the scrap­py com­pa­ny of less than 20 peo­ple to­ward a Phase 3 tri­al that could …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER